Literature DB >> 26541225

MicroRNA-340 Mediates Metabolic Shift in Oral Squamous Cell Carcinoma by Targeting Glucose Transporter-1.

Ping Xu1, Yan Li2, Haiyuan Zhang2, Mingzhe Li2, Hongwei Zhu3.   

Abstract

PURPOSE: MicroRNA-340 (miR-340) is deregulated in many human cancers in correlation with tumor progression. Recent studies have found that microRNAs play key roles in energy metabolism. This study explored the contributions of miR-340 to the metabolic shift in oral squamous cell carcinoma (OSCC).
MATERIALS AND METHODS: MiR-340 expression was measured by real-time polymerase chain reaction. MiR-340 mimics, miR-340 inhibitor, and scramble small interfering RNA were transfected into SAS human tongue SCC cells to observe their effects on cell proliferation, colony formation, lactate secretion, and glucose uptake rate. Moreover, the relation between the level of miR-340 and glucose transporter-1 (Glut1) was investigated.
RESULTS: The expression of miR-340 was decreased and thus induced a metabolic switch in oral cancer cells. The decrease in miR-340 increased Glut1 expression, leading to an increase in lactate secretion and glucose uptake rate. The altered metabolism induced by miR-340 resulted in the rapid proliferation of oral cancer cells.
CONCLUSION: The findings suggest that miR-340 might act as a molecular switch that contributes to the regulation of glycolysis in OSCC by regulating Glut1 expression.
Copyright © 2016 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26541225     DOI: 10.1016/j.joms.2015.09.038

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  16 in total

Review 1.  Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism.

Authors:  Fredy O Beltrán-Anaya; Alberto Cedro-Tanda; Alfredo Hidalgo-Miranda; Sandra L Romero-Cordoba
Journal:  Front Physiol       Date:  2016-08-08       Impact factor: 4.566

Review 2.  Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects.

Authors:  Run-Ze Shang; Shi-Bin Qu; De-Sheng Wang
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

3.  MicroRNA-340 inhibits the proliferation and promotes the apoptosis of colon cancer cells by modulating REV3L.

Authors:  Roshini Arivazhagan; Jaesuk Lee; Delger Bayarsaikhan; Peter Kwak; Myeongjoo Son; Kyunghee Byun; Ghasem Hosseini Salekdeh; Bonghee Lee
Journal:  Oncotarget       Date:  2017-12-26

4.  MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.

Authors:  L Song; P Duan; Y Gan; P Li; C Zhao; J Xu; Z Zhang; Q Zhou
Journal:  Braz J Med Biol Res       Date:  2017-04-20       Impact factor: 2.590

5.  Biomarker MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma Identified Based on Gene Expression Data and MicroRNA-mRNA Network Analysis.

Authors:  Hui Zhang; Tangxin Li; Linqing Zheng; Xiangya Huang
Journal:  Comput Math Methods Med       Date:  2017-09-17       Impact factor: 2.238

Review 6.  Micromanaging aerobic respiration and glycolysis in cancer cells.

Authors:  Ayla V Orang; Janni Petersen; Ross A McKinnon; Michael Z Michael
Journal:  Mol Metab       Date:  2019-02-06       Impact factor: 8.568

Review 7.  Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis.

Authors:  Yi-Ta Hsieh; Yi-Fen Chen; Shu-Chun Lin; Kuo-Wei Chang; Wan-Chun Li
Journal:  Int J Mol Sci       Date:  2019-08-14       Impact factor: 5.923

Review 8.  Prospective applications of microRNAs in oral cancer.

Authors:  Chuan Fang; Yadong Li
Journal:  Oncol Lett       Date:  2019-08-16       Impact factor: 2.967

9.  Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis.

Authors:  Ming Li; Feng Gao; Qing Zhao; Huilan Zuo; Wenbin Liu; Wei Li
Journal:  Cell Death Dis       Date:  2020-05-18       Impact factor: 8.469

Review 10.  Functional Landscape of Dysregulated MicroRNAs in Oral Squamous Cell Carcinoma: Clinical Implications.

Authors:  Ruma Dey Ghosh; Arun Pattatheyil; Susanta Roychoudhury
Journal:  Front Oncol       Date:  2020-05-12       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.